The Patent Finder

Terms ending in 2030

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,609,655Calcimimetic Compound for Use in the Treatment of Epithelial Injury
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,053,236Feed Media
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,228,168Feed Media
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,732,134Methods of Treating Graft Versus Host Disease Using IL-2 Muteins
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,560,415Method of Promoting Regulatory T-Cell Proliferation
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,297,248Methods of Treating Graft Versus Host Disease Using IL-2 Muteins
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,080,546Pyrazolo-Pyridinone Derivatives and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,030,354Substituted Biphenyl GPR40 Modulators
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,012,767Pipette Tip Loading Assembly
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,499,620Methods of Using an ALPHA-4-BETA-7 Heterodimer Specific Antagonist Antibody
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
64 more term ends in 2030 · Pro
10 of 74 patents shown. Soonest term end first, then patent number.
Pro members see all 74.
Upgrade to Pro
71 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited